Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Mumm

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 27, 2004
Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanismSunil Chada, Abner M Mhashilkar, Rajagopal Ramesh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2010
IL-33 induces IL-13-dependent cutaneous fibrosisAndrew L Rankin, John B Mumm, Erin Murphy, et al.
Plos One|June 15, 2016
PEGylated IL-10 Activates Kupffer Cells to Control HypercholesterolemiaIvan H Chan, Dennis Van Hoof, Marina Abramova, et al.
Molecular Cancer Therapeutics|January 21, 2003
Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cellsSuhendan Ekmekcioglu, Julie A Ellerhorst, John B Mumm, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 11, 2002
The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24Eva G Caudell, John B Mumm, Nancy Poindexter, et al.
Cancer Research|August 28, 2003
Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptorRajagopal Ramesh, Abner M Mhashilkar, Fumihiro Tanaka, et al.
Molecular Medicine (Cambridge, Mass.)|November 19, 2002
PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cellsAlexis L Stewart, Abner M Mhashilkar, Xiaohong Helena Yang, et al.
International Immunopharmacology|May 4, 2004
MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 familySunil Chada, R Bryan Sutton, Suhendan Ekmekcioglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2016
Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid TumorsAung Naing, Kyriakos P Papadopoulos, Karen A Autio, et al.
Cancer Cell|November 14, 2018
PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8<sup>+</sup> T Cell Invigoration and Polyclonal T Cell Expansion in Cancer PatientsAung Naing, Jeffrey R Infante, Kyriakos P Papadopoulos, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 27, 2004
Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanismSunil Chada, Abner M Mhashilkar, Rajagopal Ramesh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2010
IL-33 induces IL-13-dependent cutaneous fibrosisAndrew L Rankin, John B Mumm, Erin Murphy, et al.
Plos One|June 15, 2016
PEGylated IL-10 Activates Kupffer Cells to Control HypercholesterolemiaIvan H Chan, Dennis Van Hoof, Marina Abramova, et al.
Molecular Cancer Therapeutics|January 21, 2003
Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cellsSuhendan Ekmekcioglu, Julie A Ellerhorst, John B Mumm, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 11, 2002
The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24Eva G Caudell, John B Mumm, Nancy Poindexter, et al.
Cancer Research|August 28, 2003
Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptorRajagopal Ramesh, Abner M Mhashilkar, Fumihiro Tanaka, et al.
Molecular Medicine (Cambridge, Mass.)|November 19, 2002
PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cellsAlexis L Stewart, Abner M Mhashilkar, Xiaohong Helena Yang, et al.
International Immunopharmacology|May 4, 2004
MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 familySunil Chada, R Bryan Sutton, Suhendan Ekmekcioglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2016
Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid TumorsAung Naing, Kyriakos P Papadopoulos, Karen A Autio, et al.
Cancer Cell|November 14, 2018
PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8<sup>+</sup> T Cell Invigoration and Polyclonal T Cell Expansion in Cancer PatientsAung Naing, Jeffrey R Infante, Kyriakos P Papadopoulos, et al.
Pageof 3